News for Instadose Pharma Corp. (INSD)

INSD FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action – INSD, MZKR GlobeNewswire February 28, 2022 NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a...

NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose...

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Instadose Pharma Corp. f/k/a...

LOS ANGELES, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 28, 2022 deadline to...

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose" or the "Company") (OTC Other: INSD) of a...

NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...

BENSALEM, Pa., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of...

NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Instadose Pharma Corp. f/k/a...

/PRNewswire/ -- Attention Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose") (OTC Other: INSD) shareholders: The Law Offices of Vincent Wong announce...